FDA inspection
Unimed Pharmaceuticals, Inc.: FDA inspection ending Feb 14, 2023
FDA inspection 1200252 · No Action Indicated (NAI) · Cheongju
Key facts
| Inspection ID | 1200252 |
|---|---|
| Firm | Unimed Pharmaceuticals, Inc. |
| FEI number | 3013334711 |
| Address | 132 Osongsaengmyeong6-Ro; Heungdeok |
| City | Cheongju |
| Country | Korea (the Republic of) |
| Fiscal year | 2023 |
| Inspection end date | Feb 14, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data